A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)
- Status
- COMPLETED
- Phase
- N/A
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
DC1s-CTL Cellular Therapy for Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan
- Status
- COMPLETED
- Phase
- N/A
An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques
- Status
- TERMINATED
- Phase
- N/A
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- NA
NCCN Renal Cell Registry
- Status
- COMPLETED
- Phase
- NA
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- NA
A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney
- Status
- UNKNOWN
- Phase
- PHASE2
An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
- Status
- COMPLETED
- Phase
- NA
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2